[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ptc Therapeutics 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 USA

www.ptcbio.com Employees: 991 P: 908-222-7000 F: 908-222-7231

Sector:

Medical

Description:

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

Key Statistics

Overview:

Market Capitalization, $K 5,928,365
Enterprise Value, $K 7,538,715
Shares Outstanding, K 82,949
Float, K 78,387
% Float 94.50%
Short Interest, K 8,548
Short Float 10.31%
Days to Cover 10.61
Short Volume Ratio 0.77
% of Insider Shareholders 5.50%

Financials:

Annual Sales, $ 1,731 M
Annual Net Income, $ 682,640 K
Last Quarter Sales, $ 272,550 K
Last Quarter Net Income, $ -2,810 K
EBIT, $ -24,960 K
EBITDA, $ -2,950 K

Growth:

1-Year Return 57.74%
3-Year Return 22.44%
5-Year Return 81.26%
5-Year Revenue Growth 354.52%
5-Year Earnings Growth 219.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 05/07/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -2.33
EPS Growth vs. Prev Qtr 98.20%
EPS Growth vs. Prev Year -100.30%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PTCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 376.14
Price/Earnings to Growth 13.56
Return-on-Equity % -362.44%
Return-on-Assets % -6.76%
Profit Margin % 39.44%
Debt/Equity -14.49
Price/Sales 3.49
Price/Cash Flow 8.29
Price/Book N/A
Book Value/Share -2.18
Interest Coverage 5.58
60-Month Beta 0.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.